This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
NEW YORK and
June 14, 2012 /PRNewswire/ -- The McGraw-Hill Companies (NYSE: MHP), one of the world's foremost financial information companies, and CME Group (NASDAQ: CME), the world's leading and most diverse derivatives marketplace, announced today that they have received notification that the U.S. Department of Justice has completed its review of the proposed joint venture company, S&P Dow Jones Indices, and has granted early termination of the statutory waiting period. Accordingly, the condition to the formation of the joint venture related to the Hart-Scott-Rodino Antitrust Improvements Act has been satisfied. The formation remains subject to other customary closing conditions. A closing date has not yet been announced, but the S&P Dow Jones Indices joint venture is targeted to be completed by the end of June.
More information on S&P Dow Jones Indices will be published upon close of the transaction.
Forward-looking Statements: Statements in this news release that are not historical facts are forward- looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any forward-looking statements. More detailed information about factors that may affect our performance may be found in our filings with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K, which can be obtained at its Web site at
http://www.sec.gov . We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.
It is not possible to invest directly in an index. S&P Indices does not sponsor, endorse, sell, or promote any S&P index-based investment product. This document does not constitute an offer of services in jurisdictions where S&P Indices or its affiliates do not have the necessary licenses. S&P Indices receives compensation in connection with licensing its indices to third parties.